699P - Pre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer

Autor: Rasmussen, L.S., Yilmaz, M., Falkmer, U.G., Poulsen, L Ø, Bojesen, S.E., Vittrup Jensen, B., Johansen, A.Z., Chen, I.M., Hansen, C.P., Hasselby, J.P., Pfeiffer, P., Bjerregaard, J.K., Nielsen, S.E., Andersen, F.Z., Holländer, N.H., Bøgsted, M., Johansen, J.S.

Publikováno v: In Annals of Oncology October 2019 30 Supplement 5:v266-v267

776TiP - PACTO: A single center, randomized, phase II study of the combination of nab-paclitaxel and gemcitabine with or without tocilizumab, an IL-6R inhibitor, as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

Autor: Chen, I., Johansen, J.S., Zimmers, T.A., Dehlendorff, C., Kirk Parner, V., Vittrup Jensen, B., Nielsen, D.

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v266-v266

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

LBA7 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the KEYNOTE-177 study Asia subgroup.

Autor: Yoshino, T.¹ (AUTHOR), André, T.² (AUTHOR), Kim, T.W.³ (AUTHOR), Yong, W.P.⁴ (AUTHOR), Shiu, K-K.⁵ (AUTHOR), Vittrup Jensen, B.⁶ (AUTHOR), Jensen, L.H.⁷ (AUTHOR), Punt, C.J.A.⁸ (AUTHOR), Smith, D.⁹ (AUTHOR), Garcia-Carbonero, R.¹⁰ (AUTHOR), Alcaide-Garcia, J.¹¹ (AUTHOR), Gibbs, P.¹² (AUTHOR), de la Fouchardiere, C.¹³ (AUTHOR), Rivera, F.¹⁴ (AUTHOR), Elez Fernandez, M.E.¹⁵ (AUTHOR), Le, D.T.¹⁶ (AUTHOR), Zuo, Y.¹⁷ (AUTHOR), Fogelman, D.¹⁸ (AUTHOR), Adelberg, D.E.¹⁸ (AUTHOR), Diaz, L.¹⁹ (AUTHOR)

Publikováno v: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1502-S1503. 2p.